Background Acute inflammatory responses during and after percutaneous coronary intervention (PCI) are associated with subsequent cardiovascular event risk, but limited data exist on acute immune cell ...

Patients with left main coronary artery disease had similar 10-year mortality after PCI or CABG, according to new data. Read ...

A meta-analysis of long-term data suggests that both drug-eluting stent percutaneous coronary intervention (DES-PCI) and ...

The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide.

When dual antiplatelet therapy was stopped 12 months after PCI, clopidogrel monotherapy lowered cardiovascular and bleeding events relative to aspirin.

Patients with three-vessel coronary artery disease have been found to have better outcomes with coronary-artery bypass grafting (CABG) than with percutaneous coronary intervention (PCI), but studies ...

The intensity of antiplatelet therapy during percutaneous coronary intervention (PCI) is an important determinant of PCI-related ischemic complications. Cangrelor is a potent intravenous adenosine ...

Patients with CKD had twice the risk of target vessel failure after PCI compared with patients without CKD. The benefits of intravascular imaging-guided percutaneous coronary intervention (PCI) extend ...

Please provide your email address to receive an email when new articles are posted on . Abridged dual therapy followed by direct oral anticoagulant monotherapy after PCI may be safe vs. 1 year of dual ...

A statewide effort to get hospitals in Michigan to lower their procedural radiation levels for PCI resulted in a steady decrease over a 6-year period, new data show. “We were really pleased to see ...